Human ATP8B2 activation kit by CRISPRa

CAT#: GA111443

ATP8B2 CRISPRa kit - CRISPR gene activation of human ATPase phospholipid transporting 8B2



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Rabbit Polyclonal Anti-ATP8B2 Antibody
    • 100 ul

CNY 5,250.00


ATP8B2 (Myc-DDK-tagged)-Human ATPase, class I, type 8B, member 2 (ATP8B2), transcript variant 2
    • 10 ug

CNY 3,656.00
CNY 3,990.00


ATP8B2 Antibody - N-terminal region
    • 100 ul

CNY 5,250.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol ATP8B2
Locus ID 57198
Kit Components

GA111443G1, ATP8B2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA111443G2, ATP8B2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA111443G3, ATP8B2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001005855, NM_020452, NM_001370596, NM_001367934, NM_001370597
Synonyms ATPID
Summary The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of aminophospholipid-transporting ATPases. The aminophospholipid translocases transport phosphatidylserine and phosphatidylethanolamine from one side of a bilayer to another. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...